Document is current

Article History

Received: 18 September 2025

Accepted: 21 January 2026

First Online: 3 March 2026

Declarations

:

: Samantha K Kurosky and Kent Hanson designed the study. Jenny Austin, Peter Anderson, and Simran Marwaha performed statistical and qualitative analysis of the data. Samantha K Kurosky, Kent Hanson, Jenny Austin, Peter Anderson, and Simran Marwaha participated in interpretation of the data. All authors (including Chih-Chiang Chen, Chao-Chun Yang, Sung-Jan Lin, Jenny Austin, Samantha K Kurosky, Kent Hanson, Melody Yen, Peter Anderson, Gerardo A Encinas, Juliana M Canosa, Simran Marwaha, and Wen-Hung Chung) participated in drafting the manuscript, revising it critically for important intellectual content, and approved the final version to be published.

: This study was sponsored by Pfizer Inc. Pfizer also funded the journal’s Rapid Service Fee.

: Medical writing support was provided by Carolyn Maskin, PhD, of Nucleus Global and was sponsored by Pfizer Inc. During the preparation of this work, the authors used Pfizer’s generative AI assisted technology tool (GPT-4o) in order to generate the methods and results sections from an outline. The outline was drafted without the use of generative AI technology. Following the use of this tool, the authors carefully reviewed and edited the content thoroughly, performing quality control checks to ensure the text was free of errors. The authors hereby declare full responsibility for the authenticity of the contents of this publication.

: Upon request, subject to review, Pfizer will provide the data that support the findings of this study. Subject to certain criteria, conditions, and exceptions, Pfizer may also provide access to the related individual de-identified participant data. See for more information.

: Data collection was undertaken in line with European Pharmaceutical Market Research Association guidelines, and as such this study does not require ethics committee approval. The study protocol was reviewed by the Western Institutional Review Board and deemed to be exempt. The study was also conducted in accordance with the International Council for Harmonisation Guideline for Good Clinical Practice and the Declaration of Helsinki.

: Samantha K Kurosky is an employee of Pfizer Inc. and may own stock/stock options. Gerardo A Encinas and Juliana M Canosa are employees of Pfizer Inc. and own stock/stock options. Kent Hanson served as a consultant to Pfizer and received compensation for these services at the time of the study. Kent Hanson’s current affiliation is AbbVie Inc. Peter Anderson, Jenny Austin, and Simran Marwaha are employees of Adelphi Real World. Melody Yen is a Pfizer Taiwan employee. Chih-Chiang Chen, Chao-Chun Yang, Sung-Jan Lin, and Wen-Hung Chung declare no disclosures.